Title: J&J Boosts Outlook Despite Incoming Tariff Costs
Date: 2025-04-15 15:04
URL: https://finance.yahoo.com/m/7587a6b8-41b1-38a1-b035-d05170727a2f/j%26j-boosts-outlook-despite.html?.tsrc=rss

Content:
Oops, something went wrongTip: Try a valid symbol or a specific company name for relevant resultsOops, something went wrongWhy your water bill is an inflation problem that isn't budgingStock market today: Dow, S&P 500, Nasdaq futures fall as Nvidia reveals costly limits on China exportsThe Treasury secretary told Yahoo Finance that the next 90 days should provide 'substantial clarity' on tariffsTreasury Secretary Scott Bessent tells Yahoo Finance that the US has a 'big toolkit' to deal with bond market volatilityStocks drift lower as tariff chaos pauses for a dayThe chip giant committed to building AI infrastructure in the US, and Trump says he's going to help make it happen.The fallout from Trump's tariff whiplash hasn't yet pushed investors to shy away from an old habitStocks edge higher after back-to-back rallies with Trump's latest tariff moves in focusBofA's Moynihan says 'we potentially face a changing economy' after highest-ever equities trading haulThe trade war uncovers new economies of scaleTrump is wrecking his own economic agendaHigher clothing costs from tariffs are coming soon — but not immediately, experts sayWhy Tesla, GM, and Rivian will be hurt most by China's critical minerals export banTrump says he's 'looking at something' to help car companies with tariffsStocks rally for second straight day, while Apple jumps on tech tariff reprieveThe Nasdaq briefly turned red as stocks' relief rally failed to hold in early afternoon tradingAmericans are braced for the biggest unemployment rate jump since the pandemic, a New York Fed survey foundStocks surge as Apple leads way higher after tech's tariff reprieveTrump's temporary tech tariff respite adds to a growing sense that he has a willingness to listen and bendGoldman CEO Solomon warns of 'markedly different operating environment' as dealmaking slowsCorporate earnings take center stage amid tariff turmoil: What to know this weekTrump has tariffs, taxes, and the debt ceiling on a collision course for this summerTrump denies that there was a tariff “exception” for certain electronics announced Friday. (Bloomberg)Tax day 2025 is coming up. Here’s what to know to file by the deadline.Commentary: Put the P/E ratio in timeout for nowMarket chaos signals 'sell America' trade as Trump tariff whipsaw threatens to upend the US economy's soft landingApple was on brink of crisis before tariff concession from Trump (Bloomberg)Corporate earnings take center stage amid tariff turmoil: What to know this weekThe best (and worst) time of year to buy a houseThe Trump family is going all-in on crypto projects, from Bitcoin mining to stablecoins (Bloomberg)How to invest in gold in 4 stepsChanging jobs can disrupt saving for retirement. Here's how to stay on track.Trump exempts phones, computers, chips from ‘reciprocal’ tariffs (Bloomberg)Meet Walmart heir Steuart Walton, the most powerful board member you’ve never heard ofThe tariff uncertainty isn't getting any better in markets: Chart of the Week'T-shirts could be the new eggs': Why Trump's chaotic tariff whipsaw is still a huge threat to inflationGold notches best week since 2020 amid 'shaken' investor confidence in USThe bond market just had one of its most volatile and unusual weeks in recent memoryStocks capped a wild week with a surge higher, as the S&P 500 posted its biggest weekly gain since 2023Stocks swung into rally mode in afternoon trading, with the major indexes all up over 1%. Bond yields pared bigger gains.The major indexes whipsawed to end a volatile week. Treasury yields surged in signs of more instability in the bond market.Consumer sentiment craters further as inflation expectations soar to highest since 1981Dow, S&P 500, Nasdaq slide as China hits US with tariff hike, bank earnings roll inJPMorgan's Dimon says economy is facing 'considerable turbulence'Tariff uncertainty muddies — and refocuses — earnings seasonChina raises tariffs on US goods to 125% from the 84% planned in response to Trump's latest hikeChina already knows Trump's breaking point in their burgeoning trade war, our columnist writesHow the bond market helped make Trump blink on tariffsThe Dow fell 1,000 points, and the S&P 500 and Nasdaq were crushed as stocks resumed a tariff-fueled sell-offTrump's total tariff on China is actually 145%, the White House said, an amount higher than the 125% previously reportedUnlock stock picks and a broker-level newsfeed that powers Wall Street.New tariffs, primarily on medical technology products, are projected to add $400 million in costs this year, Chief Financial Officer Joseph Wolk said.Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which was performed in the clinical trial.J&J beats first-quarter earnings and sales estimates. It raises sales guidance for 2025 to reflect the addition of Caplyta from the Intra-Cellular acquisition.Johnson & Johnson is holding its earnings outlook steady despite President Donald Trump signaling he could put tariffs on the pharmaceutical industry. The administration announced earlier it would conduct an investigation into drug imports. That move is widely seen as a first step toward imposing new levies. Earnings and revenue both beat estimates for the quarter. Johnson & Johnson CFO Joe Wolk joined Bloomberg Open Interest to talk about how tariffs could hit the industry and the drug maker's bottom line.Per the latest discussion with the FDA, a confirmatory phase III study is required to seek approval for IRWD's apraglutide in short bowel syndrome with intestinal failure.J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.J&J faces several headwinds at the start of the year, including patent expiry, talc litigation, and, now, tariffs.Pre-markets are down somewhat, following yesterday's +3/4-percent gain on the Dow and the S&P 500, +2/3-percent gain for the Nasdaq.The average brokerage recommendation (ABR) for Cisco (CSCO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?C's first-quarter 2025 results benefit from a rise in NII and a fall in expenses. Rising loans and deposits balance acts as another positive.The streamer’s shares have climbed 51% over the past year, powered higher by a password-sharing crackdown and a new ads business.Tip: Try a valid symbol or a specific company name for relevant resultsSign in to access your portfolio


Try again.
